Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
PARIS (Reuters) – Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in...
N2:PHAG08
N2:BLR
N2:CMPNY
N2:DIABET
N2:DK
N2:EUROP
N2:HEA
N2:HECA
N2:INSR
N2:INSURG
N2:NAMER
N2:OBESIT
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:STKE
N2:US
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1...
N2:BIOPH
N2:BLR
N2:CMPNY
N2:HEA
N2:MRCH
N2:MTPIX
N2:NAMER
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:US
Drugmaker AbbVie expects Humira volume erosion to worsen
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of...
N2:ASIA
N2:BLR
N2:BREACA
N2:CMPNY
N2:CNCER
N2:CPROD
N2:DRUDEV
N2:EUROP
N2:GB
N2:GYNACO
N2:HEA
N2:JP
N2:MEDREG
N2:NAMER
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:SE
N2:US
N2:WOMHEA
US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors
(Reuters) – The U.S. Food and Drug Administration on Friday gave accelerated approval for the...
N2:AMERS
N2:ASIA
N2:BNKS
N2:BNKS1
N2:BSUP
N2:CARM
N2:CARM1
N2:CHIP
N2:CHIP1
N2:CMPNY
N2:COCRED
N2:COFS
N2:ELCOEQ
N2:ELEAV
N2:EUROP
N2:FIN
N2:FR
N2:HARW
N2:HELE
N2:HMAC
N2:HMAC1
N2:HOT
N2:JP
N2:LIQS
N2:LUX
N2:MTPIX
N2:NAMER
N2:OILQ
N2:PHAG08
N2:PHAR1
N2:PUBL
N2:PXP
N2:SATSER
N2:SERSYS
N2:STX
N2:TECH
N2:US
N2:WEAR
N2:WEAR1
N2:WEU
N2:WLES
N2:WLTH08
Toyota becomes Asia’s most shorted large-cap stock – Hazeltree
MILAN (Reuters) – Automaker Toyota Motor Corp became the most shorted large-cap stock by hedge...
N2:CMPNY
N2:CPROD
N2:DIABET
N2:DK
N2:DRUDEV
N2:EU
N2:EUROP
N2:GEN
N2:HEA
N2:HEARCA
N2:HECA
N2:MEDREG
N2:MTPIX
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:PXP
N2:TOPNWS
US FDA approves Novo Nordisk’s Wegovy for lowering heart risks
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration approved Novo...
N2:CHEM
N2:CMPNY
N2:DIABET
N2:DK
N2:DRUDEV
N2:ENDOCR
N2:EUROP
N2:FIN
N2:HEA
N2:MEDREG
N2:NEPHRO
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:SCI
Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics
By Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) – Novo Nordisk’s widely used diabetes drug...
N2:BACT
N2:BIZ
N2:CEEU
N2:CMPNY
N2:DE
N2:DIV
N2:EMEA
N2:EUROP
N2:EZC
N2:FIN
N2:GDY1
N2:HECA
N2:INT
N2:PHAG08
N2:PHAR
N2:PHAR08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:RES
N2:RESF
N2:TOPNWS
N2:WEU
Bayer cuts dividends to legal minimum to reduce debt
FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its dividend policy...
Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
By Bhanvi Satija (Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion,...
N2:BIODRG
N2:BLR
N2:CMPNY
N2:COVID
N2:DE
N2:EUROP
N2:HEA
N2:HECA
N2:HFAC
N2:HFAC1
N2:INFDIS
N2:MRCH
N2:MRCH1
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBHEA
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:RESPIR
N2:US
N2:VACCIN
Pfizer posts surprise 4th quarter profit, but key products miss on sales
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday,...